Jan. 10, 2019News & Opinions
France’s Sanofi is paying $462 million to exit the immuno-oncology pact it established with US biotech Regeneron in 2015 half a year earlier than planned.
Jan. 08, 2019News & Opinions
French multinational pharmaceutical company Sanofi is investing €80 million in Germany’s BioNTech. At the same time, the two companies have agreed to extend their research partnership dating from 2015.
Dec. 11, 2018News & Opinions
Sanofi is seeking to cull its workforce as it resets priorities. A French union representative told the news agency Reuters that the drugmaker is targeting 670 “voluntary departures” in particular in its human resources, IT and ...
Nov. 15, 2018News & Opinions
French drugmaker Sanofi and Denali Therapeutics of the US plan to cooperate on developing molecules discovered by Denali that have the potential to treat multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), Alzheimer's disease ...
Oct. 22, 2018News & Opinions
French drugmaker Sanofi is planning to deepen the rare diseases footprint of its Genzyme franchise at Cambridge, Massachusetts, US, where according to reports the business could move into new facilities housing about 2,000 employees.
Oct. 02, 2018News & Opinions
French drugmaker Sanofi has completed the divestment of its European generics business Zentiva to Advent International effective September 30. The transaction was finalized ahead of schedule for €1,9 billion (enterprise value). Sanofi ...
Sep. 17, 2018News & Opinions
In an unusual strategic use of human resources, European drugmakers Bayer and Sanofi are “swapping” pharmaceutical executives across continents. In one case, it is a return engagement.
Sep. 06, 2018News & Opinions
Two European drugmakers have had to deal with charges of misconduct in the US or from US authorities over the past week.
Aug. 06, 2018News & Opinions
The European Medicines Agency (EMA) is scaling back and suspending some activities as it loses more staff than initially anticipated in advance of its relocation from the UK to the Netherlands in March 2019. The agency said it now expects ...
Jul. 12, 2018News & Opinions
French drugmaker Sanofi and private equity investor Advent International have agreed a deal under which Advent will acquire Sanofi's European generics business Zentiva for €1.9 billion. Negotiations between the two companies were ...
The latest information directly via newsletter.